For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220222:nRSV3478Ca&default-theme=true
RNS Number : 3478C Transense Technologies PLC 22 February 2022
Transense Technologies plc
("Transense" or "the Company")
Grant of share options to employees
Transense Technologies plc (AIM: TRT), the developer of specialist sensor
systems, announces that it has today granted 93,000 options to acquire
ordinary shares in the Company to employees. The options have an exercise
price of 79.5 pence per share and can be exercised after three years until the
tenth anniversary of grant. None of these options were granted to directors,
and they carry specific exercise conditions related to the future financial
performance of relevant business segments.
In order to create sufficient capacity to grant these options within the
current approved limit of 10% of issued share capital, Chief Financial Officer
Melvyn Segal has elected to waive 50,000 share options granted to him on 26
June 2017 and which will be cancelled.
Following this announcement, there are now 1,582,000 unexercised share options
currently in issue under active Company schemes, representing approximately
9.62% of the current issued share capital of the Company.
For further information please visit www.transense.com or contact:
Transense Technologies plc Via Walbrook PR
Nigel Rogers (Executive Chairman)
Melvyn Segal (CFO)
Allenby Capital (Nominated Adviser and Broker) Tel: +44 (0)20 3328 5656
Jeremy Porter / George Payne (Corporate Finance)
Tony Quirke (Sales and Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780
Tom Cooper/Nick Rome/Nicholas Johnson Transense@walbrookpr.com
Notes to Editors:
Transense develops and supplies wireless sensor technology and systems. The
company has three business areas:
· SAW, patent protected Surface Acoustic Wave sensor technology that
provides real time measurement of torque, temperature, pressure and strain,
that is used to improve efficiency, performance and safety of propulsion
systems and machinery;
· Translogik, smart, connected commercial vehicle tyre inspection
equipment, used by vehicle fleets to more easily gather and maintain accurate
tyre safety and condition data; and
· iTrack, a tyre pressure monitoring system for off-highway machinery,
licensed exclusively to Bridgestone Corporation, the world's largest tyre
producer, under a ten-year deal.
Target market sectors include automotive, aerospace and industrial machinery.
The Group's strategy is to leverage excellence in innovation, know-how in
wireless sensor technologies and form industry partnerships in these global
growth sectors to maximise shareholder value through sustained revenue growth
from all three principal technologies - SAW, iTrack and Translogik.
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on
AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.
For further information please contact transense@walbrookpr.com
(mailto:transense@walbrookpr.com) .
Notes to Editors:
Transense develops and supplies wireless sensor technology and systems. The
company has three business areas:
· SAW, patent protected Surface Acoustic Wave sensor technology that
provides real time measurement of torque, temperature, pressure and strain,
that is used to improve efficiency, performance and safety of propulsion
systems and machinery;
· Translogik, smart, connected commercial vehicle tyre inspection
equipment, used by vehicle fleets to more easily gather and maintain accurate
tyre safety and condition data; and
· iTrack, a tyre pressure monitoring system for off-highway machinery,
licensed exclusively to Bridgestone Corporation, the world's largest tyre
producer, under a ten-year deal.
Target market sectors include automotive, aerospace and industrial machinery.
The Group's strategy is to leverage excellence in innovation, know-how in
wireless sensor technologies and form industry partnerships in these global
growth sectors to maximise shareholder value through sustained revenue growth
from all three principal technologies - SAW, iTrack and Translogik.
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on
AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.
For further information please contact transense@walbrookpr.com
(mailto:transense@walbrookpr.com) .
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Melvyn Segal
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Transense Technologies plc
b) LEI 2138005N52J6KKQ3EY67
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 10 pence each
Identification code GB00BDHDTH21
b) Nature of the transaction Cancellations of options
c) Price and volume Price: n/a
Volume: 50,000
d) Aggregated information
- Aggregated volume As above
- Price
e) Date of the transaction 22 February 2022
f) Place of the transaction Outside of a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOESEUESFEESESE